Benitec Biopharma (BNTC) Accounts Payables (2019 - 2024)
Benitec Biopharma (BNTC) has disclosed Accounts Payables for 6 consecutive years, with $2.4 million as the latest value for Q4 2024.
- Quarterly Accounts Payables fell 51.08% to $2.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2024, down 51.08% year-over-year, with the annual reading at $4.2 million for FY2024, 28.91% up from the prior year.
- Accounts Payables hit $2.4 million in Q4 2024 for Benitec Biopharma, down from $3.8 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $4.9 million in Q4 2023 to a low of $355000.0 in Q4 2020.
- Historically, Accounts Payables has averaged $2.2 million across 5 years, with a median of $2.0 million in 2021.
- Biggest five-year swings in Accounts Payables: plummeted 70.29% in 2020 and later surged 448.17% in 2021.
- Year by year, Accounts Payables stood at $355000.0 in 2020, then soared by 448.17% to $1.9 million in 2021, then decreased by 5.96% to $1.8 million in 2022, then soared by 169.78% to $4.9 million in 2023, then crashed by 51.08% to $2.4 million in 2024.
- Business Quant data shows Accounts Payables for BNTC at $2.4 million in Q4 2024, $3.8 million in Q3 2024, and $4.2 million in Q2 2024.